The CPASMA trial is a descriptive, prospective, multicentre clinical trial, with a before/after Continuous Positive Airway Pressure (CPAP) assessment in participating patients. It aims to answer the following question: Is there an improvement in asthma in those patients with both asthma and obstructive sleep apnoea syndrome (OSAS) treated with CPAP after six months?. It is hypothesized that treatment of OSAS with CPAP in patients with both OSAS and asthma concommitantly, may have a beneficial effect also on asthma outcomes. This clinical effect in asthma could be assessed objectively by applying validated questionnaires for quality of life and asthma control.
Full protocol in Spanish, available upon request
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
120
Continuous positive airways pressure (CPAP)
Hospital comarcal de Inca
Inca, Balearic Islands, Spain
RECRUITINGHospital Universitario Príncipe de Asturias
Alcalá de Henares, Madrid, Spain
RECRUITINGHospital de la Santa Creu i de Sant Pau
Barcelona, Spain
RECRUITINGHospital de la Santa Creu i Sant Pau
Barcelona, Spain
RECRUITINGHospital de Jerez
Cadiz, Spain
RECRUITINGHospital de Laredo
Cantabria., Spain
RECRUITINGHospital Universitario Dr. Negrín
Las Palmas, Spain
RECRUITINGHospital Moncloa
Madrid, Spain
RECRUITINGHospital Universitario Puerta de Hierro
Madrid, Spain
RECRUITINGCorporació Sanitària Parc Taulí
Sabadell, Spain
RECRUITINGAsthma control questionnaire
Changes in clinical and functional variables and in the asthma control questionnaire (ACQ) in the period prior to start the CPAP treatment and after a 6-months follow-up period
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.